Table 4.
Characteristics of different dosimetric approaches concerning acquisition timing and interpolation method.
| Investigator | Therapeutic nuclide | Acquisition timings | Interpolation method |
|---|---|---|---|
| Esser et al. [4], Sandström et al. [5], Larsson et al. [9] | 177Lu | 1, 4, 7 d | MN |
|
| |||
| Hindorf et al. [25] | 90Y | Not fixed, up to 19–48 h, 2–4 acquisitions | Not reported for kidneys |
|
| |||
| Baechler et al. [17] | 90Y, 177Lu, 111In | 0.5, 4 h, 1, 2 d | MN of last three points |
|
| |||
| Cremonesi et al. [3] | 90Y, 177Lu | 1, 4 h, 1, 2, 3 d | MN or BI |
|
| |||
| Garkavij et al. [7] | 177Lu | 1 h, 1, 4, 7 d | TRexp |